4 ms·
22 CASE STUDIES WHERE PHASE 2 AND PHASE 3 TRIALS HAD DIVERGENT RESULTS: https://www.fda.gov/media/102332/download https://www.fda.gov/media/102332/download 8 o
by ajaimk 6y ago
22 CASE STUDIES WHERE PHASE 2 AND PHASE 3 TRIALS HAD DIVERGENT RESULTS: https://www.fda.gov/media/102332/download https://www.fda.gov/media/102332/download
8 of those 22 are for "lack of safety"